Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-01-13

FDA Approved: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Original Application (Strides Pharma Science Limited)

View source ↗

Summary

FDA approved a generic fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate under an original ANDA from Strides Pharma Science Limited for …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Emtricitabine and Tenofovir Disoproxil Fumarate (emtricitabine and tenofovir disoproxil fumarate)

Snippet

ORIG AP for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)